Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration
Advances in Urology · 2012 · 2012 · 1-5
DOI: 10.1155/2012/979154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Urology, 2012. Verfasst von Masayoshi Zaitsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kanto Rosai Hospital, 1-1 Kizukisumiyoshi-cho, Nakahara-ku, Kawasaki 211-8510, Japan. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Most patients with metastatic prostate cancer are endocrinologically treated with LHRH agonist, but finally castration-refractory and hormone-refractory cancers occur. Serum testosterone levels get low to “the castration level” by LHRH agonists but may not get low enough against castration-refractory prostate cancer.
Methods
As case series, twelve patients suffering from hormone-refractory prostate cancer continuously on LHRH agonist underwent surgical castration. Additionally, one hundred and thirty-nine prostate cancer patients on LHRH agonist or surgical castration were tested for serum total testosterone levels.
Results
Surgical castration caused decrease in serum PSA in one out of 12 hormone-refractory prostate cancer patients with PSA reduction rate 74%. Serum total testosterone levels were below the sensitivity threshold (0.05 ng/mL) in 40 of 89 (44.9%) medically castrated patients and 33 of 50 (66.0%) surgically castrated patients ( P = .20 ).
Conclusion
Even hormone-refractory prostate cancer patients are candidates for surgical castration because of endocrinological, oncological, and economical reasons.
Autor:innen und Institutionen
- Department of Urology, Kanto Rosai Hospital, 1-1 Kizukisumiyoshi-cho, Nakahara-ku, Kawasaki 211-8510, Japan.
Zitieren
APA
Zaitsu, M., Yamanoi, M., Mikami, K., Takeshima, Y., Okamoto, N., Imao, S., Tonooka, A., & Takeuchi, T. (2012). Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration. Advances in Urology, 2012, 1-5. https://doi.org/10.1155/2012/979154
Vancouver
Zaitsu M, Yamanoi M, Mikami K, Takeshima Y, Okamoto N, Imao S, et al. Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration. Advances in Urology. 2012;2012:1-5. doi:10.1155/2012/979154
BibTeX
@article{Zaitsu2012,
author = {Zaitsu, Masayoshi and Yamanoi, Mariko and Mikami, Koji and Takeshima, Yuta and Okamoto, Naohiko and Imao, Sadao and Tonooka, Akiko and Takeuchi, Takumi},
title = {Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration},
journal = {Advances in Urology},
year = {2012},
volume = {2012},
pages = {1--5},
doi = {10.1155/2012/979154}
}
EUVIMED